Objective:
ermine if a dextrose-saline solution manufactured under commercial conditions and containing 1 IU per ml of heparin prolongs the use of infusion sites in children.
:
-blind randomized trial.
ts:
 children in a medical ward.
e Measures:
e of infusion sites from phlebitis and/or extravasation.
ention:
on of use of infusion sites was calculated to the nearest hour.
tics:
iate survival analysis.
s:
dian time to failure when solutions contained the heparin (97 hours) was significantly increased (p&lt;0.0001) compared with control solutions (43 hours).
sions:
 solutions containing low-dose heparin is recommended for children who might have problems with venous access.
